Correlation of Tacrolimus Levels and Metabolizer Status Based on CYP3A5 Polymorphism in Indian Lung Transplant Recipients

被引：0
|
作者：
Jindal, A. [1 ]
Rahulan, V. [1 ]
Sagadevan, S. [1 ]
Dutta, P. [1 ]
Attawar, S. [1 ]
机构：
[1] Gleneagles Global Hlth City, Inst Heart & Lung Transplant, Pulm Crit Care & Sleep Med, Chennai, Tamil Nadu, India
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.1045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1035
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 50 条
  • [31] Association between the CYP3A5*1 Allele, Tacrolimus Concentrations and Renal Function in Lung Transplant Recipients.
    Schoeppler, K.
    Kiser, T.
    Aquilante, C.
    Fish, D.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 302 - 302
  • [32] Influence of CYP3A5 and ABCB1 Polymorphism on Tacrolimus Drug Dosing in South Indian Renal Allograft Recipients
    Fernando, M. Edwin
    Sellappan, Manokaran
    Prasad, N. D. Srinivasa
    Suren, Sujit
    Thirumalvalavan, K.
    INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (04) : 261 - 266
  • [33] Association CYP3A5 gene polymorphisms with tacrolimus blood concentration in heart transplant recipients
    Gichkun, Olga
    Shevchenko, Olga
    Koloskova, Nadegda
    Shmerko, Natalia
    Ilchuk, Maria
    Shevchenko, Alex
    TRANSPLANTATION, 2024, 108 (9S)
  • [34] Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients
    Ferraresso, Mariano
    Tirelli, Amedea
    Ghio, Luciana
    Grillo, Paolo
    Martina, Valentina
    Torresani, Erminio
    Edefonti, Alberto
    PEDIATRIC TRANSPLANTATION, 2007, 11 (03) : 296 - 300
  • [35] Influence of CYP3A5 polymorphism on tacrolimus trough concentrations and acute rejection or chronic allograft nephropathy in renal transplant recipients
    Satoh, Shigeru
    Saito, Mitsuru
    Inoue, Takamitsu
    Kagaya, Hideaki
    Miura, Masatomo
    Inoue, Kazuyuki
    Habuchi, Tomonori
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 445 - 446
  • [36] COMPARISON OF TACROLIMUS STARTING DOSES BASED ON CYP3A5 PHENOTYPE OR GENOTYPE IN KIDNEY TRANSPLANT RECIPIENTS.
    Largeau, B.
    Noble, J.
    Longuet, H.
    Halimi, J.
    Buchler, M.
    Gatault, P.
    Marquet, P.
    Barin-Le Guellec, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S102 - S103
  • [37] Association CYP3A5 gene polymorphisms with tacrolimus blood concentration in heart transplant recipients
    Gichkun, Olga
    Shevchenko, Olga
    Koloskova, Nadegda
    Shmerko, Natalia
    Ilchuk, Maria
    Shevchenko, Alex
    TRANSPLANTATION, 2024, 108 (09) : 462 - 462
  • [38] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients
    Renders, L.
    Frisman, M.
    Ufer, M.
    Mosyagin, I.
    Haenisch, S.
    Ott, U.
    Caliebe, A.
    Dechant, M.
    Braun, F.
    Kunzendorf, U.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 228 - 234
  • [39] Tacrolimus Dose Requirement for Indian Liver Transplant Recipients is Less than their Western Counterparts and Varies with CYP3A5 Genotype
    Dubey, S.
    Shah, A.
    Ramakanthan, G.
    Goja, S.
    Rastogi, A.
    Soin, A.
    TRANSPLANTATION, 2017, 101 (05) : 209 - 210
  • [40] Effect of CYP3A5*1/*3 Polymorphism on Blood Pressure in Renal Transplant Recipients
    Torio, A.
    Auyanet, I.
    Montes-Ares, O.
    Guerra, R. M.
    Fernandez, E. J.
    Perez, M. A.
    Ramirez, A.
    Checa, M. D.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2596 - 2598
12345